Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEVACIZUMAB-AWWB for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 54 adverse event reports in the FDA FAERS database where BEVACIZUMAB-AWWB was used for Off label use.

Most Reported Side Effects for BEVACIZUMAB-AWWB

Side Effect Reports % Deaths Hosp.
Off label use 441 10.7% 15 58
Product storage error 437 10.6% 0 0
Circumstance or information capable of leading to medication error 346 8.4% 0 0
Hypertension 187 4.5% 4 13
Blood pressure increased 163 3.9% 0 3
Disease progression 160 3.9% 6 8
Product dose omission issue 158 3.8% 0 0
Adverse event 143 3.5% 0 1
Platelet count decreased 118 2.9% 1 3
Fatigue 104 2.5% 4 19
Intercepted product administration error 97 2.3% 0 0
Nausea 91 2.2% 3 11
Accidental exposure to product 89 2.2% 0 0
Malaise 83 2.0% 1 5
Diarrhoea 78 1.9% 3 12

Other Indications for BEVACIZUMAB-AWWB

Product used for unknown indication (2,584) Ovarian cancer (242) Colon cancer (179) Hepatocellular carcinoma (108) Colorectal cancer (96) Glioblastoma (78) Rectal cancer (77) Age-related macular degeneration (56) Adenocarcinoma of colon (50) Brain neoplasm (50)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

BEVACIZUMAB-AWWB Full Profile All Off label use Drugs BEVACIZUMAB-AWWB Demographics BEVACIZUMAB-AWWB Timeline